ACM
LAB icon

Aster Capital Management’s Standard BioTools LAB Stock Holding History

Aster Capital Management’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$445K Buy
+541,130
New +$511K 0.09% 276
2025
Q1 		– Sell
-78
Closed -$137 – 1482
2024
Q4 		$137 Buy
78
+19
+32% +$35 ﹤0.01% 1068
2024
Q3 		$114 Buy
+59
New +$116 ﹤0.01% 1067

Other funds holding LAB

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Aster Capital Management's LAB Position: Q2 2026 in Review

Aster Capital Management opened a new position in Standard BioTools (LAB) in Q2 2026: 541,130 shares worth $445K. The stake represents 0.09% of the portfolio and ranks #276 among its holdings. This is a return to the name: Aster Capital Management previously reported a position in LAB as recently as Q4 2024.

Aster Capital Management first reported a position in LAB in Q3 2024 and has held it in 3 quarters since. 144 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • Aster Capital Management held 541,130 shares of Standard BioTools worth $445K as of Q2 2026.
  • Standard BioTools was a new Aster Capital Management position in Q2 2026.
  • Standard BioTools made up 0.09% of Aster Capital Management's portfolio in Q2 2026, its #276 holding.
  • Aster Capital Management first reported a position in Standard BioTools in Q3 2024 and has held it in 3 quarters since.
  • 144 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.